Improving medication adherence for Latinx patients with hypertension
Bridging the Evidence-to-practice Gap: Evaluating Practice Facilitation as a Strategy to Accelerate Translation of a Systems-level Adherence Intervention Into Safety Net Practices
This study tests a new way to help Latinx patients with high blood pressure stick to their medication and improve their health through coaching and support.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 700 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT03713515 on ClinicalTrials.gov |
What this trial studies
This project evaluates the effectiveness of a quality improvement method called practice facilitation to enhance the implementation of an evidence-based intervention aimed at improving medication adherence and blood pressure control among Latinx patients with uncontrolled hypertension. The intervention involves identifying patients who are non-adherent to their antihypertensive medications and providing them with health coaching, care planning, and monitoring to improve their health outcomes. The study will assess the fidelity of the intervention implementation and measure clinical outcomes at 12 months.
Who should consider this trial
Good fit: Ideal candidates for this study are Latinx adults aged 18 and older with uncontrolled hypertension who are non-adherent to their antihypertensive medications.
Not a fit: Patients who are adherent to their antihypertensive medications or do not have uncontrolled hypertension may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve medication adherence and blood pressure control in Latinx patients with hypertension.
How similar studies have performed: Other studies have shown success in using practice facilitation to improve health outcomes, making this approach promising but still requiring further validation in this specific population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as Latino * Be fluent in English or Spanish * Be age 18 years or older * Receiving care in a safety-net primary care practice * Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg) * Have been prescribed at least one anti-hypertensive medication and be non- adherent to their medications, defined as adherence \<80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR. Clinic and nonclinical staff inclusion criteria: • Primary care provider (MD/DO, NP), Nurse, Medical Assistant, or administrative staff employed at the participating practices and (b) interacts with at least five patients with a diagnosis of hypertension. Exclusion Criteria: * Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks) * Participation in other hypertension-related clinical trials * Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR) * Plan to discontinue care at their practice within the next 12 months Clinic and nonclinical staff exclusion criteria: • Refuse to participate
Where this trial is running
New York, New York
- NYUMC Langone — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Antoinette Schoenthaler, EdD — NYUMC Langone
- Study coordinator: Jocelyn Cruz, MPH
- Email: Jocelyn.Acosta@nyulangone.org
- Phone: 6465013474
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.